Positive inotropic medications

35,416views

Positive inotropic medications

Critical Care - Nursing

Critical Care - Nursing

Shock: Clinical
Burns: Clinical
Asthma: Clinical
Seizures: Clinical
Skin cancer: Clinical
Neck trauma: Clinical
Stroke: Clinical
Pancreatitis: Clinical
Heart failure: Clinical
Hypertension: Clinical
Brain herniation
Concussion and traumatic brain injury
Traumatic brain injury: Pathology review
Traumatic brain injury: Clinical
Intracerebral hemorrhage
Bundle branch block
ECG basics
ECG rate and rhythm
ECG axis
ECG cardiac infarction and ischemia
Wolff-Parkinson-White syndrome
Atrioventricular block
Atrioventricular nodal reentrant tachycardia (AVNRT)
Atrial flutter
Atrial fibrillation
ECG normal sinus rhythm
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular fibrillation
Myocarditis
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Tricyclic antidepressants
Dilated cardiomyopathy
Class III antiarrhythmics: Potassium channel blockers
Positive inotropic medications
Class I antiarrhythmics: Sodium channel blockers
Coronary artery disease: Pathology review
Seizures: Pathology review
Endocarditis: Pathology review
Shock: Pathology review
Hypertension: Pathology review
Heart failure: Pathology review
Cardiomyopathies: Pathology review
Cirrhosis: Pathology review
Pancreatitis: Pathology review
Headaches: Pathology review
Ventilation-perfusion ratios and V/Q mismatch
Clinical Skills: Mechanical ventilation - conventional ventilators
Clinical Skills: High-frequency oscillatory ventilation (HFOV)
Respiratory alkalosis
Respiratory acidosis
Acute respiratory distress syndrome: Clinical
Pulmonary embolism
Acute respiratory distress syndrome
Advanced cardiac life support (ACLS): Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Obstructive lung diseases: Pathology review
Respiratory distress syndrome: Pathology review
Blood products and transfusion: Clinical
Ventilation
Anatomic and physiologic dead space
B- and T-cell memory
Zones of pulmonary blood flow
Action potentials in pacemaker cells
Reading a chest X-ray
Renal failure: Pathology review
Regulation of renal blood flow
Heart failure
Toxidromes: Clinical
Child abuse: Clinical
Carbon monoxide poisoning: Nursing process (ADPIE)
Chest trauma: Clinical
Angina pectoris
Coronary artery disease: Clinical
Antiplatelet medications
cGMP mediated smooth muscle vasodilators
Sympathomimetics: Direct agonists
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Stable angina
Ludwig angina
Unstable angina
Normal heart sounds
Abnormal heart sounds
Rheumatic heart disease
Heart blocks: Pathology review
Hypoplastic left heart syndrome
Cardiac conduction system
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Post-COVID syndrome: Heart, lungs and clotting
Myocardial infarction
Congenital heart defects: Clinical
MHC class I and MHC class II molecules
T-cell activation
Type III hypersensitivity
Antiphospholipid syndrome
B-cell activation, differentiation, and contraction
Type IV hypersensitivity
Graft-versus-host disease
Antibody classes
Type II hypersensitivity
Integrase and entry inhibitors
Small bowel ischemia and infarction
ACE inhibitors, ARBs and direct renin inhibitors
Cell-mediated immunity of CD4 cells
Cell-mediated immunity of natural killer and CD8 cells
Anaphylaxis
Shock
Hemophilia
Non-steroidal anti-inflammatory drugs
Transplant rejection
Stroke volume, ejection fraction, and cardiac output
Delirium
Dementia and delirium: Clinical
Amnesia, dissociative disorders and delirium: Pathology review
Substance misuse and addiction: Clinical
Typical antipsychotics
Metabolic and respiratory acidosis: Clinical
Dementia with Lewy bodies
Vascular dementia
Abnormal uterine bleeding: Clinical
Bleeding disorders: Clinical
Headaches: Clinical
Post-traumatic stress disorder
Trauma- and stressor-related disorders: Clinical
Clinical Skills: Pulse oximetry
Clinical Skills: BiPAP and CPAP
Anemia: Clinical
Aortic dissections and aneurysms: Pathology review
Aortic aneurysms and dissections: Clinical
Aortic dissection
Cardiac tamponade
Pericardial disease: Pathology review
Coarctation of the aorta
Hypertension
Pneumothorax
Pneumothorax: Clinical
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
General anesthetics
Emphysema
Pleural effusion: Clinical
Abdominal trauma: Clinical
Glycolysis
Carbohydrates and sugars
Oxygen-hemoglobin dissociation curve
Cellular structure and function
Fatty acid synthesis
Ketone body metabolism
Metabolic acidosis
Disorders of consciousness: Clinical
Hyperkalemia: Clinical
Acid-base disturbances: Pathology review
Plasma anion gap
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Electrolyte disturbances: Pathology review
Fatty acid oxidation
Alveolar gas equation
Gas exchange in the lungs, blood and tissues
Cardiac muscle histology
Neuromuscular blockers
Long QT syndrome and Torsade de pointes
Opioid agonists, mixed agonist-antagonists and partial agonists
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Bipolar and related disorders
Serotonin and norepinephrine reuptake inhibitors
Seizures and epilepsy
Hypertensive emergency
Hypertensive disorders of pregnancy: Clinical
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Cardiac work
Cardiac cycle
Cardiac afterload
Cardiac contractility
ECG cardiac hypertrophy and enlargement
Cardiac conduction velocity
Imaging features of COVID-19 (LifeBridge Health)
Altering cardiac and vascular function curves
Action potentials in myocytes
Resting membrane potential
Valvular heart disease: Clinical
Anatomy of the heart
Valvular heart disease: Pathology review
Premature ventricular contraction
Brugada syndrome
Premature atrial contraction
Sleep apnea
Cardiomyopathies: Clinical
Metabolic and respiratory alkalosis: Clinical
Neonatal respiratory distress syndrome
Bronchodilators: Leukotriene antagonists and methylxanthines
Hypokalemia
Hyperkalemia
Newborn management: Clinical
Carbonic anhydrase inhibitors
Regulation of pulmonary blood flow
Baroreceptors
Cranial nerves
Renin-angiotensin-aldosterone system
Anticonvulsants and anxiolytics: Barbiturates
Chronic bronchitis
Bronchiectasis
Brown-Sequard Syndrome
Bacterial epiglottitis
Ectopic pregnancy
Complications during pregnancy: Pathology review
Miscarriage
B-cell development
Placental abruption
Abnormal labor: Clinical
Ischemia
Ascending and descending spinal tracts
Spinal cord disorders: Pathology review
Pyramidal and extrapyramidal tracts
Acute kidney injury: Clinical
Free radicals and cellular injury
DNA damage and repair
Metabolic alkalosis
The role of the kidney in acid-base balance
Psychomotor stimulants
Carbon dioxide transport in blood
Acid-base map and compensatory mechanisms
Pulmonary shunts
Cardiovascular system anatomy and physiology
Pulmonary edema
Sleep disorders: Clinical

Transcript

Watch video only

Positive inotropic medications, as their name implies, are a diverse group of medications that increase the strength of heart muscle contraction.

As a result, they increase the stroke volume and thus, the cardiac output.

Positive inotropic medications include cardiac glycosides, like digoxin; beta agonists, like dobutamine; and phosphodiesterase inhibitors, like milrinone.

They are used in conditions where the heart can’t pump enough blood to the body’s tissues, like in systolic heart failure.

Alright, the heart needs to squeeze out a certain volume of blood each minute, called the cardiac output, which can be rephrased as the heart rate multiplied by the stroke volume, which is the volume of blood squeezed out with each heartbeat.

Okay, now the stroke volume depends on the preload, or the amount of blood that returns to the heart; the afterload, or peripheral resistance; and the strength of the contraction, or contractility, of the cardiac muscle.

Now, muscle contraction is initiated with an action potential which modifies receptors allowing calcium ions to flow from the sarcoplasmic reticulum into the sarcoplasm.

This allows myosin heads to bind to the actin.

These two proteins are ultimately responsible for cell contraction.

In order for a muscle to relax, calcium ions must be pumped back into the sarcoplasmic reticulum.

When the frequency of stimulation is increased, more calcium ions accumulate in the sarcoplasm, and the strength of contraction increases.

Alright, now there are conditions in which the strength of the heart’s contraction is impaired, and the heart can’t pump out enough blood to meet the body’s demands, this is called heart failure.

For example, in systolic heart failure, the heart’s ventricles can’t pump blood hard enough during systole, so as a result, the cardiac output decreases.

This is typically due to some kind of damage to the myocardium so the heart can’t contract as forcefully or pump blood as efficiently.

Ischemic heart disease caused by coronary artery atherosclerosis, or plaque buildup, is the most common cause.

Alright, now, positive inotropic medications can increase the strength of heart contraction and can be used for the treatment of these conditions.

So let’s start with the cardiac glycosides which are also known as digitalis glycosides because they’re derived from the plant digitalis.

The prototype cardiac glycoside is digoxin. Digoxin acts by inhibiting the sodium/potassium ATPase pump, at the cell membrane of the cardiomyocyte.

Na+/K+ ATPase normally moves 2 potassium ions into the cell for every 3 sodium ions out.

Now, with digoxin, potassium can’t enter the cell and sodium can’t leave it, resulting in an increase in sodium inside the cell.

But sodium finds another way to get out of the cell via the sodium/calcium exchanger that moves calcium into the cell and sodium out.

Once this extracellular calcium gets inside, it binds to receptors on the sarcoplasmic reticulum.

This releases even more calcium into the cell via a process called calcium-induced calcium release.

Now, calcium increases interaction of the two contractile proteins, actin and myosin, and ultimately improves cardiomyocyte contractility and cardiac function to reduce the symptoms of chronic heart failure.

Digoxin also exerts parasympathetic effects by inhibiting the Na+/K+ ATPase found at the cell membrane of vagal neurons leading to a decrease in heart rate.

But because parasympathetic innervation is much richer in the atria, these effects mainly involve the atria and so digoxin can also be used for the treatment of atrial arrhythmias, such as atrial flutter and atrial fibrillation.

Notice that digoxin is not considered first line treatment for heart failure or atrial arrhythmias because it has a narrow therapeutic window and it doesn’t reduce mortality in individuals with heart failure.

However, it’s a useful agent in individuals with chronic heart failure and concomitant atrial arrhythmia.

Now the narrow therapeutic window means it’s easy to overdose and digoxin has some nasty side effects.

The more common side effects include gastrointestinal disturbances such as nausea, vomiting, anorexia and diarrhea.

It could also cause electrocardiographic abnormalities, such as T wave changes, a short QT interval, ST depression, and arrhythmias.

The most common type of arrhythmia is premature ventricular contractions, although any type of arrhythmia can occur.

Also, by stimulating the vagus nerve, digoxin can lead to bradycardia and heart block.

Another side effect of digoxin is hyperkalemia, or elevated potassium levels, because digoxin doesn’t permit the potassium to enter the cells and so it accumulates in the circulation.

Now, other side effects include neurologic symptoms such as confusion, disorientation, and visual disturbances like xanthopsia, which is when objects appear yellow.

Alright, now factors that predispose to toxicity include electrolyte abnormalities like hypokalemia, or low potassium levels, hypomagnesemia, or low magnesium levels, and hypercalcemia, or elevated calcium levels.

Okay, now digoxin is excreted through the kidneys, so serum levels can increase if there’s renal dysfunction.

Key Takeaways

Positive inotropic medications are medications that increase the force of muscle contraction of the heart, resulting in an increased cardiac output. Examples of positive inotropic medications include digoxin, dobutamine, and milrinone. These medications are generally used to treat systolic heart failure, cardiogenic shock, and other heart-related conditions.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?" Cardiology (2016)
  5. "Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome" Cochrane Database of Systematic Reviews (2018)
  6. "Treatments targeting inotropy" European Heart Journal (2018)
  7. "Therapeutic achievements of phosphodiesterase inhibitors and the future" European Heart Journal (1989)